Nicergoline - Pharmacia Corporation
Alternative Names: Sermion; Sermion ZLatest Information Update: 13 Nov 2009
At a glance
- Originator Pfizer
- Class Ergolines; Small molecules; Vascular disorder therapies; Vasodilators
- Mechanism of Action Alpha adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Cerebrovascular disorders
- No development reported Alzheimer's disease
Most Recent Events
- 13 Nov 2009 No development reported - Phase-III for Alzheimer's disease in Europe (PO)
- 13 Nov 2009 No development reported - Phase-III for Alzheimer's disease in USA (PO)
- 01 Oct 2007 Mitsubishi Pharma Corporation has merged with Tanabe Seiyaku to form Mitsubishi Tanabe Pharma Corporation